Free Trial

Nutrien (NTR) Stock Forecast & Price Target

Nutrien logo
$45.90 -0.90 (-1.92%)
(As of 05:11 PM ET)

Nutrien - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
3
Hold
6
Buy
10

Based on 19 Wall Street analysts who have issued ratings for Nutrien in the last 12 months, the stock has a consensus rating of "Hold." Out of the 19 analysts, 3 have given a sell rating, 6 have given a hold rating, and 10 have given a buy rating for NTR.

Consensus Price Target

$60.33
31.45% Upside
According to the 19 analysts' twelve-month price targets for Nutrien, the average price target is $60.33. The highest price target for NTR is $76.00, while the lowest price target for NTR is $48.00. The average price target represents a forecasted upside of 31.45% from the current price of $45.90.
Get the Latest News and Ratings for NTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nutrien and its competitors.

Sign Up

NTR Analyst Ratings Over Time

TypeCurrent Forecast
11/27/23 to 11/26/24
1 Month Ago
10/28/23 to 10/27/24
3 Months Ago
8/29/23 to 8/28/24
1 Year Ago
11/27/22 to 11/27/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
10 Buy rating(s)
13 Buy rating(s)
10 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
3 Hold rating(s)
7 Hold rating(s)
Sell
3 Sell rating(s)
3 Sell rating(s)
3 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$60.33$60.67$63.78$77.65
Forecasted Upside31.45% Upside26.68% Upside33.45% Upside40.93% Upside
Consensus Rating
Hold
Hold
Moderate Buy
Moderate Buy

NTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nutrien Stock vs. The Competition

TypeNutrienBasic Materials CompaniesS&P 500
Consensus Rating Score
2.37
2.76
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside31.59% Upside127.62% Upside7.11% Upside
News Sentiment Rating
Positive News

See Recent NTR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/12/2024TD Securities
4 of 5 stars
 Lower TargetBuy$63.00 ➝ $61.00+29.32%
10/10/2024UBS Group
4 of 5 stars
J. Spector
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$66.00 ➝ $51.00+4.04%
9/24/2024Wells Fargo & Company
3 of 5 stars
R. Garchitorena
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$62.00 ➝ $50.00+5.31%
9/20/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$60.00 ➝ $60.00+25.26%
9/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Samuelson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$69.00 ➝ $53.00+14.99%
8/16/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$68.00 ➝ $55.00+18.69%
A “Thank You Gift” From Pres. Trump - Genius (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

8/12/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Outperform ➝ Sector Outperform$66.00 ➝ $59.00+26.96%
8/9/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$80.00 ➝ $75.00+63.58%
8/8/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Rodriguez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$55.00 ➝ $52.00+14.66%
8/2/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seshadri
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Moderate Sell
8/2/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Reduce
6/11/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$56.00 ➝ $55.00+3.33%
4/29/2024Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$60.00 ➝ $66.00+25.59%
3/26/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$62.00+17.92%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$66.00+26.36%
2/23/2024CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$87.00 ➝ $76.00+42.40%
2/23/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight$58.00 ➝ $48.00-11.36%
1/19/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$72.00 ➝ $75.00+49.31%
1/12/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$80.00 ➝ $65.00+22.91%
11/30/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral
7/25/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$70.00+5.69%
6/8/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$94.00 ➝ $85.00+44.73%
5/11/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$70.00 ➝ $60.00-5.30%
3/28/2023Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
1/20/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$87.00 ➝ $86.00+12.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 05:32 PM ET.


Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, November 20, 2024. Please send any questions or comments about these Nutrien pros and cons to contact@marketbeat.com.

Nutrien
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

  • Nutrien Ltd. recently announced an increase in its quarterly dividend to $0.939 per share, reflecting a strong commitment to returning value to shareholders. This increase represents an annualized dividend of $3.76, which translates to a yield of approximately 7.77%, making it an attractive option for income-focused investors.
  • The stock is currently trading at $48.32, which is below the consensus target price of $60.44. This suggests potential upside for investors looking to capitalize on price appreciation.
  • Nutrien Ltd. has a diverse business model, operating through four segments: Retail, Potash, Nitrogen, and Phosphate. This diversification can help mitigate risks associated with market fluctuations in any single segment.
  • Despite a recent earnings miss, Nutrien Ltd. reported revenue of $5.35 billion, exceeding analyst estimates. This indicates strong operational performance and resilience in a challenging market environment.
  • The company has a relatively low debt-to-equity ratio of 0.37, suggesting a conservative approach to leverage, which can be appealing to risk-averse investors.

Nutrien
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

  • Nutrien Ltd. has received multiple downgrades from analysts, with recent price targets being lowered by firms such as Mizuho and UBS Group. This could indicate a lack of confidence in the stock's near-term performance.
  • The company reported a year-over-year revenue decline of 5.0%, which may raise concerns about its growth trajectory and ability to maintain profitability in a competitive market.
  • With a current ratio of 1.26 and a quick ratio of 0.82, there are indications that Nutrien Ltd. may face challenges in meeting short-term liabilities, which could impact liquidity.
  • The stock has experienced volatility, with a beta of 0.82, suggesting that it may not be as stable as some investors prefer, especially in uncertain market conditions.
  • Analysts have assigned a consensus rating of "Hold," which may suggest that the stock is not currently viewed as a strong buy, potentially limiting upside for new investors.

NTR Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Nutrien is $60.33, with a high forecast of $76.00 and a low forecast of $48.00.

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 3 sell ratings, 6 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NTR, but not buy additional shares or sell existing shares.

According to analysts, Nutrien's stock has a predicted upside of 31.45% based on their 12-month stock forecasts.

Over the previous 90 days, Nutrien's stock had 3 downgrades by analysts.

Nutrien has been rated by research analysts at Royal Bank of Canada, TD Securities, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Nutrien less than other "basic materials" companies. The consensus rating for Nutrien is Hold while the average consensus rating for "basic materials" companies is Moderate Buy. Learn more on how NTR compares to other companies.


This page (NYSE:NTR) was last updated on 11/26/2024 by MarketBeat.com Staff
From Our Partners